Manipal Health IPO: GMP Signals Modest Premium Ahead of Opening
Anirudh Jain - Kolkata Bureau
Jul 27, 2026 1,550
Views
Manipal Health Enterprises Limited is opening its ₹9,275.22 crore IPO from July 29 to July 31, 2026, with a price band of ₹560–₹590 per share. The offering includes ₹8,000 crore in fresh equity, primarily designated for debt repayment. Shares are expected to list on BSE and NSE on August 5.
BENGALURU — Manipal Health Enterprises Limited, India's largest multispecialty hospital network by bed capacity, will launch its ₹9,275.22 crore initial public offering (IPO) on Wednesday, July 29, 2026, according to the Red Herring Prospectus (RHP) filed with market regulators. The issue, which remains open through Friday, July 31, 2026, marks one of the largest primary market offerings in the Indian healthcare sector. Unofficial market data indicates a Grey Market Premium (GMP) of ₹25 per share as of July 27, suggesting a modest listing gain of approximately 4.24% above the upper price band. The development comes as institutional and retail investors evaluate the company's valuation, balance sheet deleveraging strategy, and expanding hospital network across India.
Issue Details, Price Band, and Timelines
According to the Red Herring Prospectus submitted to the Securities and Exchange Board of India (SEBI), the price band for the IPO has been fixed at ₹560 to ₹590 per equity share of face value ₹2 each.
The total offer size of ₹9,275.22 crore comprises two main components:
Fresh Issue: ₹8,000 crore, consisting of approximately 13.56 crore equity shares.
Offer for Sale (OFS): ₹1,275.22 crore, comprising 2.16 crore equity shares offered by existing promoters and investors.
The anchor investor bidding window opens for a single day on Tuesday, July 28, 2026. Retail investors can apply for a minimum lot size of 25 equity shares, requiring a minimum investment of ₹14,750 at the upper price band. The basis of allotment is scheduled to be finalized on Monday, August 3, 2026, with the credit of shares to demat accounts slated for August 4. The stock is scheduled to list on the BSE and the National Stock Exchange (NSE) on Wednesday, August 5, 2026.
10 Key Things to Know From the RHP
1. Market Scale and Network Footprint
Manipal Health Enterprises operated 49 hospitals with 13,037 licensed beds across 14 states and union territories as of March 31, 2026. The company holds the widest geographic footprint among private hospital chains in India and is the second-largest hospital chain by total hospital count.
2. Objectives of the Fresh Issue
Of the ₹8,000 crore net proceeds from the fresh issue, the company intends to utilize ₹5,378 crore to repay or prepay outstanding debt and accrued interest availed by its subsidiary, Manipal Hospitals Private Limited. An additional ₹574 crore is earmarked to acquire a minority stake in stepdown subsidiary Sahyadri Hospitals Private Limited, with the remainder reserved for general corporate purposes.
3. Promoter and Investor Selling Shareholders
Promoter selling shareholders in the Offer for Sale include Imperius Healthcare Investments Pte. Ltd. and Manipal Education and Medical Group India Private Limited. Non-promoter investor selling shareholders include TPG SG Magazine Pte. Ltd., Seventy Second Investment Company LLC, Ammar Sdn Bhd, Novo Holdings Invest Asia A/S, and Phoenix Bear Investments, LLC.
4. Financial Performance Summary
The company reported total operational revenue of ₹10,335.75 crore in FY26, up from ₹8,242.25 crore in FY25 and ₹6,171.63 crore in FY24. Profit after tax stood at ₹892.32 crore in FY26, compared to ₹1,065.36 crore in FY25 and ₹594.32 crore in FY24. EBITDA margin reached 27.05% for FY26.
5. Regional Concentration Risk
Karnataka remains the primary revenue generator for the group. Manipal Health derived 46.40% of its operational revenue from hospitals in Karnataka in FY26, down from 51.55% in FY25 and 59.98% in FY24. The RHP explicitly notes that localized operational disruptions or regulatory shifts in Karnataka could impact overall financial performance.
6. Industry Landscape
According to the RHP, the Indian healthcare delivery market reached ₹7.6–7.8 lakh crore in FY26. The In-Patient Department (IPD) segment accounted for 71–72% of total market value, remaining the primary revenue driver for multi-specialty care facilities despite outpatient volumes being higher.
7. Valuation and Key Ratios
At the upper price band of ₹590 per share, the company's pre-IPO price-to-earnings (P/E) ratio stands at 75.93 based on FY26 earnings, while the post-IPO P/E ratio is estimated at 84.65. Return on Net Worth (RoNW) was reported at 10.57% and Return on Capital Employed (ROCE) stood at 21.88% for FY26.
8. Employee Reservation and Discount
The issue includes a reserved portion for eligible employees valued at ₹15 crore. Eligible employees are offered shares at a discount of ₹56 per share relative to the final offer price.
9. Listed Industry Peers
In its filing, the company lists Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, and Max Healthcare Institute Limited as its primary listed industry peers.
10. Book Running Lead Managers and Registrar
The global coordinator and book-running lead managers for the issue include Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited, UBS Securities India Private Limited, and DBS Bank India Limited. KFin Technologies Limited is serving as the registrar.
Grey Market Premium and Market Sentiment
Market observers note that the grey market premium for the Manipal Health IPO has remained stable at ₹25 per share through July 25–27, 2026. At a price of ₹590, the estimated listing price in the unofficial market is ₹615, reflecting a modest 4.24% premium. Financial analysts point out that while grey market trends offer early indications of investor appetite, they are unofficial and do not guarantee actual exchange performance on the listing date.
Official Sources Section
All factual data, operational figures, financial metrics, and offering timelines in this article are derived directly from the Red Herring Prospectus (RHP) filed by Manipal Health Enterprises Limited with SEBI, regulatory filings on the stock exchanges, and official announcements issued by the lead managers and company promoters.
Quote Section
"As of March 31, 2026, we operated 49 hospitals with 13,037 licensed beds across 14 states and union territories," stated company management in the official Red Herring Prospectus. "We have the widest footprint in terms of presence of hospitals among private hospital chains in India as of March 31, 2026, and represent the largest pan-India multispecialty hospital network by bed capacity."
Why It Matters
The capital raised from the fresh issue will substantially reduce the company's debt burden, lowering interest expenses and strengthening net margins. For capital markets, this public issue serves as a major benchmark for healthcare sector valuations in India, reflecting how public markets value large-scale tertiary and quaternary care providers undergoing aggressive expansion.
Key Facts at a Glance
Issue Window: Opens July 29, 2026; Closes July 31, 2026.
Hospital Capacity: 49 hospitals and 13,037 licensed beds across 14 states/UTs.
Tentative Listing Date: August 5, 2026, on NSE and BSE.
Frequently Asked Questions
What is the price band and lot size for the Manipal Health IPO?
The price band is set at ₹560 to ₹590 per equity share. The minimum lot size for retail investors is 25 shares, which requires an investment of ₹14,750 at the upper price limit.
What is the primary purpose of the IPO funds?
The fresh issue proceeds of ₹8,000 crore will be utilized primarily to repay ₹5,378 crore of outstanding debt and accrued interest of subsidiary Manipal Hospitals, while ₹574 crore will fund the acquisition of a minority stake in Sahyadri Hospitals.
When will shares be allotted and listed on the stock exchanges?
Share allotment is scheduled for finalization on August 3, 2026. The equity shares are expected to list on the BSE and NSE on August 5, 2026.
